Clinical Trials Logo

Clinical Trial Summary

This is a prospective, open-label, multiple center and single arm phase 2 study to evaluate the efficacy and safety of T cells expressing humanized CD7 chimeric antigen receptors treatment for patients with refractory/relapsed CD7 positive T cell lymphoma.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05059912
Study type Interventional
Source The First Affiliated Hospital of Soochow University
Contact Caixia Li, M.D
Phone +86 512 67781856
Email [email protected]
Status Recruiting
Phase Phase 2
Start date August 5, 2021
Completion date August 3, 2024